Federal regulators Tuesday approved for sale in the United States a mechanical pump built by a Framingham company as a “bridge therapy” to support heart function and blood flow in patients with end-stage heart failure who are awaiting a heart trans…
The Food and Drug Administration announced Tuesday that it has approved Framingham, Massachussetts-based HeartWare’s left ventricle assist device for heart failure patients awaiting a heart transplant. The HeartWare Ventricular Assist System is a mec…
WASHINGTON (AP) â?? The Food and Drug Administration on Tuesday approved a new heart pump for patients with severe heart failure who are awaiting a heart transplant.
The Food and Drug Administration on Tuesday approved a new heart pump for patients with severe heart failure who are awaiting a heart transplant.Regulators approved HeartWare's Ventricular Assist System, …
The U.S. Food and Drug Administration today approved the HeartWare Ventricular Assist System, a left ventricular assist device (LVAD), to support heart function and blood flow in patients with end-stage heart failure who are awaiting a heart transplant.
Scientists have reversed paralysis in dogs after injecting them with cells grown from the lining of their nose. The pets had all suffered spinal injuries which prevented them from using their back legs.
Scientists have reversed paralysis in dogs after injecting them with cells grown from the lining of their nose, offering new hope for paralysed humans.
Physicians wonder why Ontario’s health ministry is taking so long to approve a promising hepatitis C drug approved by the feds and available in seven other provinces
Drugmaker Pfizer Inc. expects to pay about $825 million to resolve government and civil lawsuits involving numerous medicines, according to a filing with regulators.
ZURICH (Reuters) – Swiss pharmaceutical company Novartis said on Monday its Certican, an immune system drug also known under the names Afinitor and Votubia, showed positive outcomes in a two-year phase III study in liver transplantation. The study, whi…